VIP modulates the pro-inflammatory maternal response, inducing tolerance to trophoblast cells

British Journal of Pharmacology

Volumn 156, Issue 1, 2009, Pages 116-126

  Fraccaroli, Laura ^a   Alfieri, Julio ^a   Larocca, Luciana ^a   Calafat, Mario ^a   Roca, Valeria ^a   Lombardi, Eduardo ^b   Ramhorst, Rosanna ^a   Leirós, Claudia Pérez ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b IFER   (Argentina)

Author keywords

Early pregnancy; Human implantation; Tolerance and pregnancy; VIP

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; NITRITE; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE ANTAGONIST; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR; AUTACOID;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL LINE; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; DOSE RESPONSE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; INFLAMMATION; NIDATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; SWAN 71 CELL; TROPHOBLAST; WESTERN BLOTTING; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; IMMUNOLOGY; METABOLISM; MONONUCLEAR CELL; PREGNANCY;

CELL LINE; CELL PROLIFERATION; COCULTURE TECHNIQUES; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO IMPLANTATION; FEMALE; HUMANS; IMMUNE TOLERANCE; INFLAMMATION MEDIATORS; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; PREGNANCY; RECEPTORS, VASOACTIVE INTESTINAL PEPTIDE; TROPHOBLASTS; VASOACTIVE INTESTINAL PEPTIDE;

EID: 65549103356     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2008.00055.x     Document Type: Article

References (53)

1. Abad C, Martinez C, Juarranz MG, Arranz A, Receta J, Delgado M et al. (2003). Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease. Gastroenterol 124 : 961 971.
2. Abrahams V, Visitin I, Aldo P, Guller S, Romero R, Mor G (2005). A role for TLRs in the regulation of immune cell migration by first trimester trophoblast cells. J Immunol 176 : 8096 8104.
3. Alexander SPH, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edition. Br J Pharmacol 153 (Suppl. 2 S1 209.
4. Aluvihare V, Kallikourdis M, Betz AG (2004). Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 5 : 266 271.
5. Aplin JD, Straszewski-Chavez SL, Kalions B, Dunk C, Morrish D, Forbes K et al. (2006). Trophoblast differentiation: progenitor cells, fusion and migration. A workshop report. Placenta 27 (Suppl. A S141.
6. Armstrong BD, Hu Z, Abad C, Yamamoto M, Rodriguez WI, Cheng J et al. (2003). Lymphocyte regulation of neuropeptide gene expression after neuronal injury. J Neurosci Res 15 : 240 247.
7. Arranz A, Juarranz Y, Leceta J, Gomariz RP, Martínez C (2008). VIP balances innate and adaptive immune responses induced by specific stimulation of TLR2 and TLR4. Peptides 29 : 948 956.
8. Arruvito L, Sanz M, Banham A, Fainboim L (2007). Expansion of CD4+CD25+FOXP3+ regulatory T cells during the follicular phase of the menstrual cycle: implications for human reproduction. J Immunol 178 : 2572 2578.
9. Auchincloss H Jr., Sachs DH (1998). Xenogeneic transplantation. Annu Rev Immunol 16 : 433 470.
10. Blois SM, Ilarregui JM, Tometten M, Garcia M, Orsa LAS, Cordo-Russo R, Toscano MA, Bianco GA, Kobelt P, Handjiski B, Tirado I, Markert UR, Klapp BF, Poirier F, Szekeres-Bartho J, Rabinovich GA, Arck PC (2007). A pivotal role for galectin-1 in fetomaternal tolerance. Nat Med 13 : 1450 1457.
11. Bulletti C, Flamigni C, de Ziegler D (2005). Implantation markers and endometriosis. Reprod Biomed Online 11 : 464 468.
12. Bulmer JN, Sunderland C (1984). Immunological characterization of lymphoid cell populations in the early human placental bed. Immunology 52 : 349 357.
13. Chaouat G, Zourbas S, Ostoij S, Lappree-Delage G, Dubanchet S, Ledee N et al. (2002). A brief review of recent data on some cytokine expressions at the materno-fetal interface which might challenge the classical Th1/Th2 dichotomy. J Reprod Immunol 53 : 241 253.
14. Chaouat G, Ledee-Bataille N, Dubanchet S, Zourbas S, Sandra O, Martal J (2004). TH1/TH2 paradigm in pregnancy: paradigm lost? Cytokines in pregnancy/early abortion: reexamining the TH1/TH2 paradigm. Int Arch Allergy Immunol 134 : 93 119.
15. Chaouat G, Dubanchet S, Ledée N (2007). Cytokines: important for implantation? J Assist Reprod Genet 24 : 491 505.
16. Chorny A, Gonzalez-Rey E, Fernandez Martin A, Ganea D, Delgado M (2006). Vasointestinal peptide induces regulatory dendritic cells that prevent acute graft-host disease while maintaining the graft-versus tumor response. Blood 107 : 3787 3794.
17. Clark DA, Chaouat G, Gorczynsk G (2002). Thinking outside the box: mechanisms of environmental selective pressures on the outcome of the materno-fetal relationship. Am J Reprod Immunol 47 : 275 282.
18. Clark KE, Mills EG, Stys SJ, Seeds AE (1981). Effects of vasoactive polypeptides on the uterine vasculature. Am J Obstet and Gynecol 139 : 182 188.
19. Delgado M, Munoz-Elias EJ, Gomariz RP, Ganea D (1999). Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies. J Immunol 1 : 1707 1716. (Pubitemid 29307049)
20. Delgado M, Abad C, Martinez C, Receta J, Gomariz RP (2001). Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat Med 7 : 563 568.
21. Delgado M, Abad C, Martinez C, Juarranz MG (2002). Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases. J Mol Med 80 : 16 24.
22. Deon D, Ahmed S, Tai K, Scaletta N, Herrero C, Lee IH et al. (2001). Cross-talk between IL-1 and IL-6 signaling pathways in rheumatoid arthritis synovial fibroblasts. J Immunol 1 : 5395 5403.
23. Dimitriadis E, White CA, Jones RL, Salamonsen LA (2005). Cytokines, chemokines and growth factors in endometrium related to implantation. Hum Reprod Update 11 : 613 630.
24. Ding AH, Nathan CF, Stuehr DJ (1988). Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 141 : 2404 2412.
25. Domínguez F, Martínez S, Quiñonero A, Loro F, Horcajadas JA, Pellicer A et al. (2008). CXCL10 and IL-6 induce chemotaxis in human trophoblast cell lines. Mol Hum Reprod 14 : 423 430.
26. Ekström J, Mansson B, Tobin G (1983). Vasoactive intestinal peptide evokes secretion of fluid and protein from rat salivary glands and the development of supersensitivity. Acta Physiol Scand 199 : 169 175.
27. Fest S, Aldo P, Abrahams VM, Alvero I, Chen R, Chavez SL et al. (2000). Trophoblast-macrophage Interactions: a Regulatory network for the protection of pregnancy. Am J Reprod Immunol 5 : 55 66.
28. Gomariz RP, Martinez C, Abadd C, Leceta J, Delgado M (2001). Immunology of VIP: a review and therapeutical perspectives. Curr Pharm Des 7 : 89 111.
29. Gonzalez-Rey E, Anderson P, Delgado M (2007). Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy. Ann Rheum Dis 66 : 70 76.
30. Gressens P, Paindaveine B, Hill JM, Evrard P, Brenneman DE (1998). Vasoactive intestinal peptide shortens both G1 and S phases of neural cell cycle in whole postimplantation cultured mouse embryos. Eur J Neurosci 10 : 1734 1742.
31. Gutiérrez-Cañas I, Rodríguez-Henche N, Bolaños O, Carmena MJ, Prieto JC, Juarranz MG (2003). VIP and PACAP are autocrine factors that protect the androgen-independent prostate cancer cell line PC-3 from apoptosis induced by serum withdrawal. Br J Pharmacol 139 : 1050 1058.
32. Gutiérrez-Cañas I, Juarranz Y, Santiago B, Arranz A, Martinez C, Galindo M et al. (2006). VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts. Rheumatology 45 : 527 532.
33. Henson PM, Bratton DL, Fadok VA (2001). The phosphatidylserine receptor: a crucial molecular switch? Nat Rev Mol Cell Biol 2 : 627 633.
34. Inoue Y, Kaku K, Kaneko T, Yanahara N, Kanno T (1985). Vasoactive intestinal peptide binding to specific receptors on rat parotid acinar cells induces amylase secretion accompanied by cyclic adenosine 3′-5′- monophosphate. Endocrinology 116 : 686 692.
35. Jovanovic A, Jovanovic S, Tulic I, Grbovic L (1998). Predominant role for nitric oxide in the relaxation induced by vasoactive intestinal polypeptide in human uterine artery. Mol Hum Reprod 4 : 71 76.
36. Kawano Y, Fukuda J, Nasu K, Matsumoto H, Narahara H, Miyakawa I (2004). Synergistic effect of interleukin (IL)-1alpha and ceramide analogue on the production of IL-6, IL-8, and macrophage colony-stimulating factor by endometrial stromal cells. Fertil Steril 3 : 1043 1047.
37. Killedar SJ, Eckenrode SE, McIndoe RA, She JX, Nguyen CQ, Peck AB et al. (2006). Early pathogenic events associated with Sjögren's syndrome (SjS)-like disease of the NOD mouse using microarray analysis. Lab Invest 86 : 1243 1260.
38. Larocca L, Calafat M, Roca V, Franchi AM, Leirós CP (2007). VIP limits LPS-induced nitric oxide production through IL-10 in NOD mice macrophages. Int Immunopharmacol 10 : 1343 1349.
39. Larocca L, Ramhorst R, Roca V, Calafat M, Aisemberg J, Franchi A, Pérez-Leirós (2008). Neuroimmune-endocrine interactions during early pregnancy in an autoimmune context: focus on macrophage activation. Neuroimmunemodulation 15 : 84 90.
40. Mauri C, Williams RO, Walmsley M, Feldmann M (1996). Relationship between Th1/Th2 cytokine patterns ans arthritogenic response in collagen-induced arthritis. Eur J Immunol 26 : 1511 1520.
41. Paria B, Reese J, Das S, Dey S (2002). Deciphering the cross talk of implantation: advances and challenges. Science 296 : 2185 2188.
42. Piccinni MP (2007). Role of T-cell cytokines in decidua and in cumulus oophorus during pregnancy. Gynecol Obstet Invest 64 : 144 148.
43. Pregi N, Vittori D, Pérez G, Pérez Leirós C, Nesse A (2006). Effect of erythropoietin on staurosporine-induced apoptosis and differentiation of SH-SY5Y neuroblastoma cells. Biochim Biophys Acta 1763 : 238 246.
44. Rosignoli F, Torraoba M, Juarranz J, Garcia-Gomez M, Martinez C, Gomariz RP et al. (2006). VIP and tolerance induction in autoimmunity. Ann N Y Acad Sci 1070 : 525 530.
45. Rugeles MT, Shearer GM (2004). Alloantigen recognition in utero: dual advantage for the fetus? Trends Immunol 25 : 348 352.
46. Saito S (2000). Cytokine network at feto-maternal interface. J Reprod Immunol 47 : 87 103.
47. Sherman LA, Chattopadhyay S (1993). The molecular basis of allorecognition. Annu Rev Immunol 11 : 385 402.
48. Song H, Lim H (2006). Evidence for heterodimeric association of leukemia inhibitory factor (LIF) receptor and gp130 in the mouse uterus for LIF signaling during blastocyst implantation. Reproduction 131 : 341 349.
49. Spong C, Lee S, Mcune S, Gibney G, Abebe D, Alvero R et al. (1999). Maternal regulation of embryonic growth: the role of vasoactive intestinal peptide. Endocrinology 140 : 917 924. (Pubitemid 29058231)
50. Sreedharan SP, Huang JX, Cheung MC, Goetzl EJ (1995). Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene. Proc Natl Acad Sci USA 92 : 2939 2943.
51. Terness P, Kallikourdis M, Betz AG, Rabinovich GA, Saito S, Clark DA (2007). Tolerance signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells. Am J Reprod Immunol 58 : 238 254.
52. Thellin O, Coumans B, Zorzi W, Igout A, Heinen A (2000). Tolerance to the foeto-placental 'graft': ten ways to support a child for nine months. Curr Opin Immunol 12 : 731 737.
53. Wheeler S, Eardley JE, McNulty KF, Sutcliffe CP, Morrison JD (1997). An investigation into the relative merits of pituitary adenylate cyclase-activating polypeptide (PACAP-27) and vasoactive intestinal polypeptide as vagal neuro-transmitters in exocrine pancreas of rats. Exp Physiol 82 : 729 747.